Post by Kinan Muhammed, MD PhD

Very pleased to now be able to share Kneu Health has been awarded UKRI Innovate UK funding as part of the UK Government’s Department for Science, Innovation and Technology dementia research initiative, recognising us as one of the innovative players in the field. We’ll be combining our smartphone-based digital cognitive assessments with blood biomarkers in partnership with Dementias Platform UK READ-OUT study to enable earlier and more accurate diagnosis of cognitive conditions. One aim is by 2029, over 92% of patients could receive a diagnosis within 18 weeks of a doctor’s referral, which would be a huge step forward! You can read the government press release below, which includes Kneu Health. Alzheimer's Society Alzheimer's Research UK.